Minyong Kang
Papers
11
Total Citations
144
H-Index
7
About
Minyong Kang is a leading urologic surgeon and researcher whose work centers on advancing robotic surgery for urologic cancers, particularly renal cell carcinoma and upper tract urothelial carcinoma. His major contributions include defining and refining the "Pentafecta" and "Tetrafecta" outcome standards for robot-assisted partial nephrectomy and radical cystectomy, providing benchmarks for surgical success that integrate oncologic control, functional preservation, and complication avoidance. His highly cited studies—such as those on predictive factors for superior Pentafecta outcomes (33 citations) and comparisons of transperitoneal versus retroperitoneal robotic partial nephrectomy for large tumors (33 citations)—have directly shaped surgical decision-making. Kang has also led trend analyses of robotic radical nephroureterectomy, demonstrating its growing utilization and comparative advantages over open and laparoscopic approaches. With over 140 total citations across his top papers, his work is widely recognized for its practical impact on improving perioperative outcomes and standardizing quality metrics in minimally invasive urologic oncology. His ongoing research continues to push the boundaries of robotic surgery, making him a key figure in the field.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6How far has robot-assisted partial nephrectomy reached?10 citations · 2023
- 7
- 8
- 9
- 10